These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 8748407

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Indications for tacrolimus anti-rejection therapy in liver allograft recipients.
    Jonas S, Bechstein WO, Tullius SG, Steinmüller T, Gamm T, Neuhaus P.
    Transpl Int; 1996; 9 Suppl 1():S164-70. PubMed ID: 8959817
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Management of acute steroid-resistant rejection after liver transplantation.
    Platz KP, Mueller AR, Zytowski M, Lemmens P, Lobeck H, Neuhaus P.
    World J Surg; 1996 Oct; 20(8):1052-8; discussion 1058-9. PubMed ID: 8798364
    [Abstract] [Full Text] [Related]

  • 5. Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection.
    Millis JM, Woodle ES, Piper JB, Bruce DS, Newell KA, Seaman DS, Baker AL, Hart J, Dasgupta K, Thistlethwaite JR.
    Transplantation; 1996 May 15; 61(9):1365-9. PubMed ID: 8629298
    [Abstract] [Full Text] [Related]

  • 6. Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients.
    Millis JM, Bruce DS, Newell KA, Piper JB, Woodle ES, Seaman DS, Baker AL, Hart J, Dasgupta K, Thistlethwaite JR.
    Transplant Proc; 1996 Apr 15; 28(2):1014. PubMed ID: 8623213
    [No Abstract] [Full Text] [Related]

  • 7. OKT3 vs FK 506 rescue management of acute steroid-resistant and chronic rejection.
    Platz KP, Mueller AR, Zytowski M, Bechstein WO, Blumhardt G, Lobeck H, Neuhaus P.
    Transplant Proc; 1995 Feb 15; 27(1):1111-3. PubMed ID: 7533357
    [No Abstract] [Full Text] [Related]

  • 8. OKT3 therapy in addition to tacrolimus is associated with improved long-term function in patients with steroid refractory renal allograft rejection.
    Patschan D, Kribben A, Pietruck F, Lutz J, Binek M, Philipp T, Heemann U, Witzke O.
    Nephron Clin Pract; 2006 Feb 15; 103(3):c94-9. PubMed ID: 16534238
    [Abstract] [Full Text] [Related]

  • 9. Initial experience with tacrolimus rescue therapy in OKT3 resistant rejection.
    Herget S, Heemann U, Friedrich J, Kribben A, Wagner K, Philipp T.
    Clin Nephrol; 1996 May 15; 45(5):352-4. PubMed ID: 8738671
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection.
    Reyes J, Jain A, Mazariegos G, Kashyap R, Green M, Iurlano K, Fung J.
    Transplantation; 2000 Jun 27; 69(12):2573-80. PubMed ID: 10910279
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug 27; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 16. Does initial graft function influence the outcome after liver transplantation?
    Mueller AR, Platz KP, Krause P, Neuhaus R, Lobeck H, Neuhaus P.
    Transplant Proc; 1998 Jun 27; 30(4):1464-5. PubMed ID: 9636594
    [No Abstract] [Full Text] [Related]

  • 17. Rejection and tacrolimus conversion therapy in paediatric liver transplantation.
    Spada M, Corno V, Colledan M, Segalin A, Lucianetti A, Torre G, Riva S, Sonzogni A, Petz W, Gridelli B.
    Transpl Int; 2000 Jun 27; 13 Suppl 1():S341-4. PubMed ID: 11112028
    [Abstract] [Full Text] [Related]

  • 18. Successful use of tacrolimus for initial rejection episodes after liver transplantation.
    Millis JM, Cronin DC, Newell KA, Bruce DS, Woodle ES, Grewal HP, Loss GE, Lissoos T, Conjeevaram H, Schiano T, O'Laughlin R, Charette J, McNaughton M, Baker AL, Thistlethwaite JR.
    Transplant Proc; 1998 Jun 27; 30(4):1407-8. PubMed ID: 9636569
    [No Abstract] [Full Text] [Related]

  • 19. FK 506 and mycofenolate mofetil rescue for acute steroid-resistant and chronic rejection after liver transplantation.
    Platz KP, Mueller AR, Neuhaus R, Keck HH, Lobeck H, Neuhaus P.
    Transplant Proc; 1997 Nov 27; 29(7):2872-4. PubMed ID: 9365598
    [No Abstract] [Full Text] [Related]

  • 20. Anti-lymphocyte therapy successfully controls late "cholestatic" rejection in pediatric liver transplant recipients.
    Kerkar N, Morotti RA, Iyer K, Arnon R, Miloh T, Sturdevant M, Suchy F, Florman S, Emre S.
    Clin Transplant; 2011 Nov 27; 25(6):E584-91. PubMed ID: 21919961
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.